Researchmoz added Most up-to-date research on "Global Pneumococcal Vaccine Market 2016-2020" to its huge collection of research reports.
Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen.
Technavios analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent pneumococcal infections.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775742
Technavio's report, Global Pneumococcal Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline (GSK)
Merck
Pfizer
Sanofi
Other prominent vendors
Abera
AstraZeneca
Baxter
Beijing Minhai Biotechnology
Biken
Biogen
Celgene
Eli Lilly
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Panacea Biotec (India)
S K Chemicals
Serum Institute of India
Sinovac
Valneva Austria
Market driver
Inclusion in NIP
For a full, detailed list, view our report
Market challenge
Inadequate vaccine coverage
For a full, detailed list, view our report
Market trend
Expansion of marketing territories
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775742
Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people (65 years and older), and it is among the leading infectious disease. It kills almost 1.6 million people (including over 800,000 children under five years) every year. It can be prevented by vaccination and involves the introduction of a dead or weakened antigen into the human body. This produces lymphocytes to counter the infection and any future invasions by that antigen.
Technavios analysts forecast the global pneumococcal vaccine market to grow at a CAGR of 13.69% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pneumococcal vaccine market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent pneumococcal infections.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775742
Technavio's report, Global Pneumococcal Vaccine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline (GSK)
Merck
Pfizer
Sanofi
Other prominent vendors
Abera
AstraZeneca
Baxter
Beijing Minhai Biotechnology
Biken
Biogen
Celgene
Eli Lilly
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Panacea Biotec (India)
S K Chemicals
Serum Institute of India
Sinovac
Valneva Austria
Market driver
Inclusion in NIP
For a full, detailed list, view our report
Market challenge
Inadequate vaccine coverage
For a full, detailed list, view our report
Market trend
Expansion of marketing territories
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775742
No comments:
Post a Comment